UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and Are Safe for Single‐Stage Cartilage Repair in Humans upon Mixture with Recycled Autologous Chondrons

Stem cells (Dayton, Ohio), 2017-01, Vol.35 (1), p.256-264

2017

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One‐Stage Cartilage Cell Transplantion: A First‐in‐Man Trial in 35 Patients

Stem cells (Dayton, Ohio), 2017-08, Vol.35 (8), p.1984-1993

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

Circulation (New York, N.Y.), 2015-03, Vol.131 (10), p.851-860

2015

Link zum Volltext

Verfügbarkeit prüfen

Direct Cell-Cell Contact with Chondrocytes Is a Key Mechanism in Multipotent Mesenchymal Stromal Cell-Mediated Chondrogenesis

Tissue engineering. Part A, 2015-10, Vol.21 (19-20), p.2536

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review

Stem cell research & therapy, 2015-05, Vol.6 (1), p.94-94, Article 94

2015

Link zum Volltext

Verfügbarkeit prüfen

Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries

Cytotherapy (Oxford, England), 2020-10, Vol.22 (10), p.592-600

2020

Link zum Volltext

Verfügbarkeit prüfen

Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

Rheumatology (Oxford, England), 2019-10, Vol.58 (10), p.1812-1817

2019

Link zum Volltext

Verfügbarkeit prüfen

Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum

Tissue engineering. Part A, 2009-12, Vol.15 (12), p.3741

2009

Link zum Volltext

Verfügbarkeit prüfen

Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions

PloS one, 2014-11, Vol.9 (11), p.e112339-e112339

2014

Link zum Volltext

Verfügbarkeit prüfen

Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2011-05, Vol.29 (15), p.1980-1986

2011

Link zum Volltext

Verfügbarkeit prüfen

Current Regulations for the Production of Multipotent Mesenchymal Stromal Cells for Clinical Application

Transfusion medicine and hemotherapy, 2008-01, Vol.35 (4), p.295-298

Slaper-Cortenbach, Ineke C.M.

2008

Link zum Volltext

Verfügbarkeit prüfen

Standards for the Terminology and Labeling of Cellular Therapy Products

Transfusion (Philadelphia, Pa.), 2007-07, Vol.47 (7), p.1319-1327

2007

Link zum Volltext

Verfügbarkeit prüfen

ISBT 128 Implementation Plan for Cellular Therapy Products

Transfusion (Philadelphia, Pa.), 2007-07, Vol.47 (7), p.1312-1318

2007

Link zum Volltext

Verfügbarkeit prüfen

A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Experimental hematology, 2003-10, Vol.31 (10), p.855-864

2003

Link zum Volltext

Verfügbarkeit prüfen

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with b‐cell malignancies

Cancer, 1994-02, Vol.73 (S3), p.1006-1011

1994

Link zum Volltext

Verfügbarkeit prüfen

The survey on cellular and engineered tissue therapies in Europe in 2009

Tissue engineering. Part A, 2011-09, Vol.17 (17-18), p.2221

2011

Link zum Volltext

Verfügbarkeit prüfen

Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation

British journal of haematology, 2000-11, Vol.111 (2), p.674-684

2000

Link zum Volltext

Verfügbarkeit prüfen

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa

Journal of investigative dermatology, 2015-09, Vol.135 (9), p.2319-2321

2015

Link zum Volltext

Verfügbarkeit prüfen

Establishing consensus on ethics, traceability and biovigilance for medical products of human origin

Bulletin of the World Health Organization, 2021-12, Vol.99 (12), p.907-909

2021

Link zum Volltext

Verfügbarkeit prüfen

The Value of Flow Cytometric Analysis of Platelet Glycoprotein Expression on CD34+ Cells Measured Under Conditions That Prevent P-Selectin–Mediated Binding of Platelets

Blood, 1995-11, Vol.86 (10), p.3771-3782

1995

Link zum Volltext

Verfügbarkeit prüfen

ISBT 128 implementation plan for cellular therapy products

Journal of clinical apheresis, 2007-01, Vol.22 (5), p.258-264

2007

Link zum Volltext

Verfügbarkeit prüfen

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

British journal of haematology, 1996-03, Vol.92 (4), p.922-928

1996

Link zum Volltext

Verfügbarkeit prüfen

Core diameter of bone marrow aspiration devices influences cell density of bone marrow aspirate in patients with severe peripheral artery disease

Cytotherapy (Oxford, England), 2015-12, Vol.17 (12), p.1807-1812

2015

Link zum Volltext

Verfügbarkeit prüfen

Standards for the terminology and labeling of cellular therapy products

Journal of clinical apheresis, 2007-01, Vol.22 (5), p.249-257

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Humans
(43)
Life Sciences & Biomedicine
(43)
Hematology
(27)
Biological And Medical Sciences
(19)
Cell Biology
(15)
Female
(15)
Medical Sciences
(15)
Male
(14)
Cell & Tissue Engineering
(11)
Adult
(10)
Treatment Outcome
(9)
Child
(8)
Medicine, Research & Experimental
(8)
Research & Experimental Medicine
(8)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(7)
Biotechnology & Applied Microbiology
(7)
Bone Marrow
(7)
Hematopoietic Stem Cell Transplantation
(7)
Middle Aged
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and Are Safe for Single‐Stage Cartilage Repair in Humans upon Mixture with Recycled Autologous Chondrons

Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One‐Stage Cartilage Cell Transplantion: A First‐in‐Man Trial in 35 Patients

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

Direct Cell-Cell Contact with Chondrocytes Is a Key Mechanism in Multipotent Mesenchymal Stromal Cell-Mediated Chondrogenesis

Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review

Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries

Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum

Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions

Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation

Current Regulations for the Production of Multipotent Mesenchymal Stromal Cells for Clinical Application

Standards for the Terminology and Labeling of Cellular Therapy Products

ISBT 128 Implementation Plan for Cellular Therapy Products

A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with b‐cell malignancies

The survey on cellular and engineered tissue therapies in Europe in 2009

Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa

Establishing consensus on ethics, traceability and biovigilance for medical products of human origin

The Value of Flow Cytometric Analysis of Platelet Glycoprotein Expression on CD34+ Cells Measured Under Conditions That Prevent P-Selectin–Mediated Binding of Platelets

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

ISBT 128 implementation plan for cellular therapy products

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

Core diameter of bone marrow aspiration devices influences cell density of bone marrow aspirate in patients with severe peripheral artery disease

Standards for the terminology and labeling of cellular therapy products

Suchergebnisse filtern